D. Fırat

907 total citations
46 papers, 680 citations indexed

About

D. Fırat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, D. Fırat has authored 46 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Pathology and Forensic Medicine. Recurrent topics in D. Fırat's work include Cancer Treatment and Pharmacology (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). D. Fırat is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). D. Fırat collaborates with scholars based in Türkiye, United States and Japan. D. Fırat's co-authors include Joseph E. Sokal, Leon Stutzman, Ayşe Kars, C. William Aungst, Ediz Z. Ezdinli, Gülten Tekuzman, İbrahim Güllü, İbrahim Barışta, Emin Kansu and Nilüfer Güler and has published in prestigious journals such as Cancer, The American Journal of Medicine and The Journal of Urology.

In The Last Decade

D. Fırat

46 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Fırat Türkiye 14 192 153 144 130 115 46 680
Umihiko Sawada Japan 14 258 1.3× 194 1.3× 132 0.9× 74 0.6× 132 1.1× 77 691
S A Rosenberg United States 8 264 1.4× 64 0.4× 62 0.4× 161 1.2× 223 1.9× 10 946
Bunshiro Akikusa Japan 17 117 0.6× 90 0.6× 42 0.3× 116 0.9× 192 1.7× 52 832
Abe M Japan 12 104 0.5× 84 0.5× 291 2.0× 123 0.9× 82 0.7× 134 768
Horacio Oliva Spain 13 148 0.8× 176 1.2× 246 1.7× 106 0.8× 152 1.3× 17 760
Emanuela Ricotti Italy 14 116 0.6× 67 0.4× 156 1.1× 98 0.8× 168 1.5× 22 681
Peter R. Graze United States 10 222 1.2× 118 0.8× 111 0.8× 183 1.4× 68 0.6× 15 726
Nanette McAtee United States 12 377 2.0× 105 0.7× 128 0.9× 169 1.3× 241 2.1× 16 1.0k
Rainer Krech Germany 16 142 0.7× 149 1.0× 36 0.3× 135 1.0× 230 2.0× 38 705
Y Carcassonne France 17 278 1.4× 174 1.1× 64 0.4× 133 1.0× 179 1.6× 115 1.1k

Countries citing papers authored by D. Fırat

Since Specialization
Citations

This map shows the geographic impact of D. Fırat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Fırat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Fırat more than expected).

Fields of papers citing papers by D. Fırat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Fırat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Fırat. The network helps show where D. Fırat may publish in the future.

Co-authorship network of co-authors of D. Fırat

This figure shows the co-authorship network connecting the top 25 collaborators of D. Fırat. A scholar is included among the top collaborators of D. Fırat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Fırat. D. Fırat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barışta, İbrahim, Ayşe Kars, Şevket Ruacan, et al.. (2000). Primary Breast Lymphomas: A Retrospective Analysis of Twelve Cases. Acta Oncologica. 39(2). 135–139. 34 indexed citations
2.
Günel, Nazan, et al.. (1999). Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Preliminary Report. Tumori Journal. 85(6). 483–487. 6 indexed citations
3.
4.
Koç, Yener, Görgün Akpek, Emin Kansu, et al.. (1998). Bolus and Continuous Infusion Mitoxantrone in Newly Diagnosed Adult Acute Lymphoblastic Leukemia: Results of Two Consecutive Phase II Clinical Studies: Original Articles. Cancer Investigation. 16(6). 355–365. 4 indexed citations
5.
Gündüz, Miyase Gözde, A. Ayhan, İbrahim Güllü, et al.. (1997). nm23 Protein expression in larynx cancer and the relationship with metastasis. European Journal of Cancer. 33(14). 2338–2341. 19 indexed citations
6.
Kars, Ayşe, İ. Çelik, Emin Kansu, et al.. (1997). Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma. European Journal Of Haematology. 59(2). 100–104. 8 indexed citations
7.
Kostakoğlu, Lale, et al.. (1997). Can bone scintigraphy detect additional metastatic sites unrevealed by CT in patients with recurrent ovarian carcinoma?. PubMed. 15(1). 55–8. 1 indexed citations
8.
Kiraz, Sedat, İbrahim Barışta, İ. Çelik, et al.. (1996). Ifosfamide, Mesna and Epirubicin as Second-Line Chemotherapy in Advanced Breast Cancer. Journal of Chemotherapy. 8(4). 310–314. 5 indexed citations
9.
Güllü, İbrahim, Şuayib Yalçın, Gülten Tekuzman, et al.. (1996). High-Dose Ifosfamide by Infusion with Mesna in Advanced Refractory Sarcomas. Cancer Investigation. 14(3). 239–242. 8 indexed citations
10.
Güllü, İbrahim, İ. Çelik, Gülten Tekuzman, et al.. (1996). Procarbazine, Ccnu, Vincristine Combination in the Treatment of Brain Tumors. Tumori Journal. 82(3). 228–231. 3 indexed citations
11.
Yalçın, Şuayib, Nilüfer Güler, Emin Kansu, et al.. (1996). Granulocyte—Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced Neutropenia. Hematology. 1(2). 155–161. 8 indexed citations
12.
Fırat, D.. (1996). Tobacco and cancer in Turkey.. PubMed. 15(2-4). 155–60. 15 indexed citations
13.
Barışta, İbrahim, İbrahim Güllü, Nilüfer Güler, et al.. (1996). Factors Influencing the Distribution of Metastases and Survival in Metastatic Breast Carcinoma. American Journal of Clinical Oncology. 19(6). 569–573. 7 indexed citations
14.
Yalçın, Şuayib, İbrahim Barışta, Gülten Tekuzman, İbrahim Güllü, & D. Fırat. (1996). Dramatic Response to Ifosfamide, Mesna and Doxorubicin Chemotherapy Regimen in an Adult With Clear Cell Sarcoma of the Kidney. The Journal of Urology. 155(6). 2024–2024. 7 indexed citations
15.
Beneklı, Mustafa, İbrahim Güllü, Abdurrahman Kadayıfçı, et al.. (1995). Tumor Lysis Syndrome Following Single-Dose Mitoxantrone. Chemotherapy. 41(6). 470–472. 7 indexed citations
16.
Özyılkan, E, et al.. (1992). Ceruloplasmin Level in Women with Breast Disease Preliminary Results. Acta Oncologica. 31(8). 843–846. 14 indexed citations
17.
Kansu, Emin, et al.. (1988). A rapid drug sensitivity assay for neoplasmatic cells. Medical Oncology and Tumor Pharmacotherapy. 5(4). 253–257. 10 indexed citations
18.
Fırat, D., et al.. (1971). Acute leukemia, following treatment with irradiation and alkylating agent.. PubMed. 71(20). 2422–5. 11 indexed citations
19.
Ezdinli, Ediz Z., Leon Stutzman, C. William Aungst, & D. Fırat. (1969). Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia. Cancer. 23(4). 900–909. 56 indexed citations
20.
Fırat, D. & Leon Stutzman. (1968). Fibrous dysplasia of the bone. The American Journal of Medicine. 44(3). 421–429. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Umihiko Sawada Breakdown of academic impact, for papers by S A Rosenberg Breakdown of academic impact, for papers by Bunshiro Akikusa Breakdown of academic impact, for papers by Abe M Breakdown of academic impact, for papers by Horacio Oliva Breakdown of academic impact, for papers by Emanuela Ricotti Breakdown of academic impact, for papers by Peter R. Graze Breakdown of academic impact, for papers by Nanette McAtee Breakdown of academic impact, for papers by Rainer Krech Breakdown of academic impact, for papers by Y Carcassonne
Rankless by CCL
2026